Biojo Sciences
Biojo Sciences is a global biopharmaceutical company focused on developing novel clinical-stage therapies to improve patient and family lives. They leverage an efficient development process through effective operations, licensing, and partnerships, targeting a diverse range of diseases including oncology, neurology, rare diseases, and cell & gene platforms. Their mission emphasizes creating therapeutic value through innovative science, collaboration, and integrity, aiming to deliver early-stage drugs and emerging platforms to patients in need.
Industries
Nr. of Employees
small (1-50)
Biojo Sciences
3 Bethesda Metro Center, Suite 700, Bethesda, Maryland 20814, United States of America
Products
Clinical-Stage Therapies
Biojo Sciences develops therapies in clinical stages, focusing on areas like oncology, neurology, rare diseases, and cell & gene platforms.
Clinical-Stage Therapies
Biojo Sciences develops therapies in clinical stages, focusing on areas like oncology, neurology, rare diseases, and cell & gene platforms.
Licensing and Partnerships
The company commercializes drug assets through licensing and strategic partnerships, enhancing their portfolio with diverse therapeutic areas.
Licensing and Partnerships
The company commercializes drug assets through licensing and strategic partnerships, enhancing their portfolio with diverse therapeutic areas.
Pipeline Development
Biojo Sciences builds a diversified portfolio by acquiring rights to promising therapies and funding their clinical development.
Pipeline Development
Biojo Sciences builds a diversified portfolio by acquiring rights to promising therapies and funding their clinical development.
Clinical-Stage Therapies
Biojo Sciences develops therapies in clinical stages, focusing on areas like oncology, neurology, rare diseases, and cell & gene platforms.
Clinical-Stage Therapies
Biojo Sciences develops therapies in clinical stages, focusing on areas like oncology, neurology, rare diseases, and cell & gene platforms.
Licensing and Partnerships
The company commercializes drug assets through licensing and strategic partnerships, enhancing their portfolio with diverse therapeutic areas.
Licensing and Partnerships
The company commercializes drug assets through licensing and strategic partnerships, enhancing their portfolio with diverse therapeutic areas.
Pipeline Development
Biojo Sciences builds a diversified portfolio by acquiring rights to promising therapies and funding their clinical development.
Pipeline Development
Biojo Sciences builds a diversified portfolio by acquiring rights to promising therapies and funding their clinical development.
Services
Structuring licensing agreements, joint ventures and strategic partnerships to advance clinical-stage therapeutics toward commercialization.
Providing or facilitating capital to acquire therapeutic rights and fund mid-stage clinical development programs.
Operational design and program-specific process support to accelerate development timelines and prepare assets for commercialization or licensing.
Structuring licensing agreements, joint ventures and strategic partnerships to advance clinical-stage therapeutics toward commercialization.
Providing or facilitating capital to acquire therapeutic rights and fund mid-stage clinical development programs.
Operational design and program-specific process support to accelerate development timelines and prepare assets for commercialization or licensing.
Expertise Areas
- Clinical trial management and clinical development
- Licensing, partnerships and joint ventures
- Regulatory strategy and multi-jurisdictional market access
- Portfolio management and therapeutic asset due diligence
Key Technologies
- Biologics
- Cell and gene therapy platforms
- Immuno-oncology approaches
- Clinical-stage therapeutic development
News & Updates
The world can't wait for what begins at BIO 2025—and neither…
Be at the forefront of change with the largest oncology research…
Where Business + Breakthroughs Converge The BIO International…
Join Biojo Sciences at the J.P. Morgan Healthcare Conference. Meet with us through the BIO Partnering at JPM system.
The world can't wait for what begins at BIO 2025—and neither…
Be at the forefront of change with the largest oncology research…
Where Business + Breakthroughs Converge The BIO International…
Join Biojo Sciences at the J.P. Morgan Healthcare Conference. Meet with us through the BIO Partnering at JPM system.